Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells

While treatment for B-cell malignancies has been revolutionized through the advent of CAR immunotherapy, similar strategies for T-cell malignancies have been limited. Additionally, T-cell leukemias and lymphomas can commonly metastasize to the CNS, where outcomes are poor and treatment options are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jia, Xu, Haichan, Cinquina, Andrew, Wu, Zehua, Chen, Qi, Zhang, Ping, Wang, Xingen, Shan, Huiming, Xu, Lei, Zhang, Qian, Sun, Lihua, Zhang, Wenli, Pinz, Kevin G., Wada, Masayuki, Jiang, Xun, Hanes, William M, Ma, Yupo, Zhang, Hongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036178/
https://www.ncbi.nlm.nih.gov/pubmed/33410096
http://dx.doi.org/10.1007/s12015-020-10092-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036178/
https://www.ncbi.nlm.nih.gov/pubmed/33410096
http://dx.doi.org/10.1007/s12015-020-10092-9

Ejemplares similares